Track sentiment, discussions and live quotes, post ideas and see what real traders are doing

Qualcomms reported performance-focused global layoffs are drawing attention, with traders divided between viewing the cuts as a sign of underperformance and as potential cost discipline; the number of jobs affected has not been specified. Discussion also centers on the stocks relative strength against weaker chip peers and its setup ahead of earnings.

Eli Lillys early Phase 1 results for its investigational ovarian-cancer ADC combination are drawing attention, with traders highlighting the reported 79% response rate and 100% disease-control rate. The findings are an early-stage pipeline development, while the broader discussion also includes mixed reactions to LLYs share-price moves.

Disney is drawing attention for a gradual technical rebound, with traders citing bullish momentum and watching whether shares can break through recent resistance ahead of the next earnings report. Others say repeated rejection at resistance and the stocks long-running lack of appreciation could stall the move.

Reports that Instacart is exploring a sale, with Uber among the preliminary potential buyers, have traders debating whether grocery delivery would add strategic value or bring costly acquisition and antitrust risks; some also speculate Uber has stepped back from talks. The discussion is mixed, with the deal seen by some as a growth opportunity and by others as an unwanted spending burden amid ongoing frustration with UBERs weak share performance.

Intuits latest results beat expectations, but its FY27 outlook and lowered growth ambitions disappointed investors, prompting a sharp selloff and analyst downgrades. Traders are debating whether slower customer growth and cheaper AI-powered tax alternatives threaten TurboTax and QuickBooks, while bulls argue Intuits established products and financial data remain defensible.

Attention centers on Candels CAN-2409 prostate cancer program, especially its planned BLA submission in the fourth quarter of 2026, with clinical updates and upcoming NSCLC and glioblastoma presentations adding speculative interest. Bullish traders point to the data and regulatory progress, while others focus on the sharp pullback, possible dilution, and concern about the filing timeline and CEO share sales.

SHIB is drawing attention around a prolonged consolidation and traders debate over whether it can break higher with a broader meme-coin or altcoin rally. Bullish holders are accumulating and anticipating a rebound, while skeptics cite its stagnant performance, limited utility, and lack of meaningful token burns.

Reported takeover interest from Lundbeck has fueled speculation about a potential acquisition, with traders debating possible offers despite Xeris saying it is not for sale and no deal being confirmed. The discussion is also supported by optimism about Recorlevs growth and XP-8121s long-term potential, while some traders caution that the pipeline remains years from commercialization.

Crudes rally amid escalating Houthi attacks and fears of Middle East supply disruptions is driving attention to UCO, a leveraged crude-oil fund. Traders are split between buying the momentum or using UCO as a hedge and expecting a pullback if tensions ease or a deal emerges.

Valero is drawing attention for record results powered by unusually strong refining margins, as fuel-supply disruptions and tight diesel markets support crack spreads. Traders are split between viewing the fundamentals as a tailwind and warning that the sharp rally may be vulnerable to profit-taking, shifting oil flows, and policy headlines.